Jingjing Li

12PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 23, 2026
DDR1 sustains ferroptosis resistance in pancreatic ductal adenocarcinoma via SLC40A1-mediated iron homeostasis.

|Jul 17, 2026
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development.

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Aug 07, 2025
PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Bing Zhu, Ning Ma, Zhi-Chao Liu

|Jan 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Kang Wang, Yan-Jun Xiang, Hong-Ming Yu

|Dec 14, 2023
XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.

Ji Xia, Ning Ma, Qian Shi

Pageof 2

Frequent Collaborators

9 joint publications

Ning Ma

6 joint publications

Dong Xie

4 joint publications

Shuqun Cheng

4 joint publications

Yan-Jun Xiang